Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

An actively recruiting clinical trial is seeking to evaluate a new drug to treat diabetic kidney disease (DKD). This new injectable drug will be given alongside Farxiga...
Encouraging trial results from Novo Nordisk show that a new combination therapy in development could help people lower their A1C and weight dramatically. With the...
Approximately 17% of people with diabetes have diabetic cardiomyopathy, a dangerous complication that can lead to heart failure. This clinical trial is focused on...
The recently passed Inflation Reduction Act includes new policies that cap the monthly cost of insulin at $35 and potentially reduce the cost of other diabetes drugs for...
The ready-to-use autoinjector emergency glucagon pen is now available for people over the age of two in the US
GLP-1 agonists are a class of drug recommended for people with type 2 diabetes to lower glucose and body weight, and for heart and stroke protection in those with heart...
Chronic obesity-related health conditions such as type 2 diabetes, insulin resistance, high blood pressure, and fatty liver disease were previously only seen in adults...
diaTribe’s Julie Heverly had the opportunity to try the new Tandem mobile app, which allows users to administer insulin boluses directly from their smartphones. Here’s...
Lilly has just announced that it will discontinue manufacturing its Glucagon Emergency Kits. Read why the company took this step and what your options are to access...
In the search for new and innovative ways to treat type 1 diabetes, researchers have looked to develop therapies that protect or improve the body’s ability to produce...
Insulin pens and pumps are two of the most popular choices for insulin delivery. The CeQur Simplicity aims to combine the strengths of both of these technologies.
The FDA approved Beovu (brolucizumab) to treat diabetic macular edema for people with type 1 or type 2 diabetes. This medication could potentially help you or someone...
Researchers are dedicated to developing new mealtime insulins that can help improve glucose management and prevent highs and lows. Exciting new concentrated, ultra-rapid...
While African Americans, Hispanic/Latino Americans, and Indigenous people can be nearly twice as likely to have diabetes as white Americans, these populations are less...
The financial burden of managing diabetes can be overwhelming. Sanofi has updated its Valyou Savings Program to make insulin more affordable for those who are uninsured...
Are you an adult with type 2 diabetes who is interested in trying oral insulin? If so, see if you’re eligible for this clinical trial studying how an oral insulin pill...
Explore the unique challenges faced by transgender individuals managing diabetes, from health inequities to hormone therapy effects. Discover personal stories, advice,...
Sanofi is giving access to a 30-day supply of medicine for those waiting for their Patient Connection program application to be processed
For people with diabetes, using a reliable and safe method of birth control is essential in avoiding an unplanned, and potentially dangerous, pregnancy. By understanding...
Insulin has come a long way since its discovery over 100 years ago. Learn what new insulin options may be on the horizon that could revolutionize the way diabetes is...

Pages